MedPath

Standard Cut Rate 27-Gauge System Versus Ultrahigh-Speed 27-Gauge System in Macular Surgery

Not Applicable
Conditions
Macular Disease
Interventions
Device: Ultrahigh-speed cut rate 27-gauge system
Device: Standard cut rate 27-gauge system
Registration Number
NCT05497128
Lead Sponsor
Seoul National University Bundang Hospital
Brief Summary

The purpose of this study is to compare the efficiency and safety of ultrahigh-speed cut rate 27-gauge system (27+®GA HYPERVIT® Vitrectomy Probe (Alcon Laboratories, Fort Worth, TX, USA)) and standard cut rate 27-gauge vitrectomy system (27+®GA Advanced ULTRAVIT® Vitrectomy Probe (Alcon Laboratories, Fort Worth, TX, USA)).

Detailed Description

During the last few decades, there have been dramatic changes in vitreoretinal surgery field with improvements in the performance of surgical retina equipment. As the innovation trend has been moving toward the smaller instrument calibers, the 27-gauge vitrectomy system has been developed. However, the vitrectomy system with the smaller calibers have limitations such as reduced instrument rigidity, limited availability of instrumentation, and decreased flow rate. To overcome these limitations, active developments have been ongoing to increase vitreous cutting speed, enlargement of the cutting port size, and enlargement of inner shaft to enable higher flow rates. Especially, the ultrahigh-speed cutter with improved cutting speed has the advantage of enabling safer vitrectomy because the faster cutting speed reduces retinal movement and minimizes the risk of iatrogenic retinal breaks. However, ultrahigh-speed cutting has a limitation in that it can reduce the flow rate through the vitreous cutter as it affects the duty cycle (percentage of time the cutter port is open relative to the complete cutting cycle). Therefore, the duty cycle of ultrahigh-speed cutter has also been improved so as not to delay the time for vitrectomy.

The investigators would like to evaluate the efficiency and safety of vitrectomy using a recently released ultra high-speed cut rate 27-gauge system (27+®GA HYPERVIT® Vitrectomy Probe (Alcon Laboratories, Fort Worth, TX, USA)) and a standard cut rate 27-gauge system (27+®GA Advanced ULTRAVIT® Vitrectomy Probe (Alcon Laboratories, Fort Worth, TX, USA)) by comparing the duration of vitrectomy and the rate of complications.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
66
Inclusion Criteria
  • All consecutive eyes requiring macular surgery (i.e. epiretinal membrane, vitreomacular traction etc.) that underwent 27-gauge vitrectomy at Seoul National University Bundang Hospital (SNUBH) from September 2022 to August 2023. Patients will be randomized to receive 27-gauge vitrectomy with 20,000 cpm probes (20K group) or 27-gauge vitrectomy with 10,000 cpm probes (standard group).
Exclusion Criteria
  1. Previously vitrectomized eye
  2. Trauma cases
  3. Proliferative diabetic retinopathy with fibrovascular membranes
  4. Retinal detachment with proliferative vitreoretinopathy
  5. Macular hole
  6. Endophthalmitis
  7. Inability to consent for procedure

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Ultrahigh-speed cut rate 27-gauge systemUltrahigh-speed cut rate 27-gauge systemPatients will receive the pars plana vitrectomy in the macular disease with the 27-gauge vitrectomy systems with 20,000 cpm probes.
Standard cut rate 27-gauge systemStandard cut rate 27-gauge systemPatients will receive the pars plana vitrectomy in the macular disease with the 27-gauge vitrectomy systems with 10,000 cpm probes.
Primary Outcome Measures
NameTimeMethod
Efficiency of core vitrectomyDuring the vitrectomy

Time to completion of core vitrectomy

Secondary Outcome Measures
NameTimeMethod
Efficiency of peripheral vitrectomyDuring the vitrectomy

Time to completion of peripheral vitrectomy

Intraoperative complicationsDuring the vitrectomy

i.e. iatrogenic retinal breaks, intraocular bleeding, retinal detachment, etc.

Efficiency of surgeryDuring the surgery

Time to completion of the surgery

Postoperative complicationsPostoperative period within 4 months after the vitrectomy

i.e. intraocular bleeding, retinal detachment, etc.

Trial Locations

Locations (1)

Seoul National University Bundang Hospital

🇰🇷

Seongnam, Gyunggi-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath